Test,.Bank:
Advanced,.Pharmacology,.for,.Prescribers,.1st,.Edition,.Luu,.Kayingo,.Latest,
.Edition,,.2024
, Table,.of,.Contents
Chapter,. 1:,. An,.Introduction,. to,.Evidence-Based,.Clinical,. Practice,.Guidelines........................................ 3
Chapter,. 2:,.Pharmacokinetics ,. /Chapter3:,.Pharmacodynamics ............................................................... 13
Chapter4:,.Pharmacogenetics,. and,.Pharmacogenomics ........................................................................... 25
Chapter,. 5:,.Pharmacology,. Across,.the,.Life,.Span .................................................................................. 30
Chapter,. 6:,.Drug-Therapy,.Prescribing,. in,.Special,.Populations .............................................................. 36
Chapter,. 7:,.Drug,.Development ,. and,. Approval....................................................................................... 45
Chapter,.8-Chapter,.10:,.Foundations,.of,.Prescription,.Writing,.Chapter,.9:,.ResponsibleControlled-
Substance,.Prescribing,.Chapter,.10:,.Antibiotic,.Stewardship ................................................................... 51
Chapter,. 11:,. Applied,.Calculations,. for,. Prescribing ................................................................................ 58
Chapter,.12-:,.Promoting,.Adherence,.With,.Pharmacotherapy,.II:,.System-Specific,.and,.Patient-
Focused,.Prescribing,.Chapter,.13:,.Pharmacotherapy,.for,.Ear,,.Nose,,.Mouth,,.andThroat,.Conditions,./Chapt
er,.14:,.Pharmacotherapy,.for,.Eye,.Conditions.......................................................................................... 67
Chapter,. 15:,.Pharmacotherapy,.for,. Skin,.Conditions .............................................................................. 74
Chapter,. 16:,.Pharmacotherapy,.for,. Neurologic,. Conditions .................................................................... 81
Chapter,. 17:,.Pharmacotherapy,.for,. Cardiovascular,. Conditions ............................................................. 94
Chapter,. 18:,.Pharmacotherapy,. for,. Respiratory,.Conditions ................................................................. 106
Chapter,.19:,.Pharmacotherapy,.for,.Gastrointestinal,.Conditions,.and,.Conditions,.RequiringNutritional,.Sup
port ...................................................................................................................................................... 117
Chapter,. 20:,.Pharmacotherapy,.for,. Genitourinary,.Conditions.............................................................. 128
Chapter,.21:,.Pharmacotherapy,.for,. Renal,,. Acid–Base,,. Fluid, ,.and,.Electrolyte,.Disorders .................... 133
Chapter,. 22:,.Pharmacotherapy,.for,. Musculoskeletal,. and,. Rheumatologic,. Conditions ......................... 146
Chapter,. 23:,.Therapeutic,. Applications,. of,. Immunology,. and,. Vaccines ............................................... 158
Chapter,. 24:,.Pharmacotherapy,.for,. Endocrine,.Disorders ..................................................................... 163
Chapter,. 25:,.Pharmacotherapy,.for,.Hematologic,. Disorders ................................................................. 174
Chapter,. 26:,.Hematology/Oncology,.and,.Supportive,. Care,.for,. the,.Nononcologist .............................. 190
Chapter, . 27:,.Pharmacotherapy,. Related,. to,.Women’s,. Health,. Conditions ............................................ 196
Chapter,.28:,.Pharmacotherapy,. Related,.to,.Men’s,. Health,. Conditions ................................................. 211
Chapter,. 29:,.Pharmacotherapy,. Related,. to,.Transgender,. Care ............................................................. 217
Chapter,. 30:,. Antimicrobial,.Pharmacotherapy ...................................................................................... 224
Chapter,. 31:,. Antiretroviral,.Pharmacotherapy....................................................................................... 235
Chapter,.32:,.Psychopharmacology,.and,.Integrative,.Health:,.Combined,.Treatment,.ofPsychiatric,.and,.Neur
ocognitive,.Conditions .......................................................................................................................... 247
Chapter, . 33:,.Pharmacotherapy,. for,. Pain,.Management ......................................................................... 257
Chapter,. 34:,.Substance,. Use,.Disorder,. III:,.Health,.Promotion,.and,.Maintenance .................................. 267
Chapter,. 35:,.Over-the-Counter,. Medications ........................................................................................ 283
Chapter,. 36:,.Pharmacotherapy,.for,. Obesity .......................................................................................... 291
,Chapter,.1:,.An,. Introduction,. to,.Evidence-Based,. Clinical,.Practice,.Guidelines
MULTIPLE,.CHOICE
• What,. is,.the,.primary,.purpose,. of,.the,. nursing, . assessment?
A. Identifying,. underlying, . pathologic, . conditions
B. Assisting,. the,. physician,. in,. identifying,. medical,. conditions
C. Determining,. the,. patients,.mental,.status
D. Exploring,. patient,. responses,. to, . health,. problems
ANS:,.D
A,.nursing,.assessment,.is,.done,.to,.identify,.the,.patients,.response,.to,.health,.
problems.,.During,.the,.nursing,.assessment,.phase,,.a,.comprehensive,.inform
ation,.base,.is,.developed,.through,.a,.physical,.examination,,.nursing,.history,,
.medication,.history,,.and,.professional,.observation.,.Identifying,.underlying,
.pathologic,.conditions,.and,.assisting ,.the,.physician,.in,.identifying,.medical,.
conditions,.is,.not,.part,.of,.the,.nursing,.process.,.Determining,.the,.patients, .
mental,.status, . is, . one,.part, . of,.the, . nursing, . assessment,, . but, . it, . is, . not,.the,
.primary,.purpose.
DIF:,.Cognitive,.Level:,.Comprehension
,.REF:,.dm,.36 ,.OBJ:,.1,.|,.3,.TOP:,.Nursin
g,.Process,.Step:,.Assessment
MSC:,.NCLEX,. Client,. Needs,. Category:,. Health,.Promotion,. and,. Maintenance
• What,.is,.the,.basis,. of,.the,.NANDA,.I, . taxonomy?
A. Functional,. health,.patterns
B. Human,.response,. patterns
C. Basic,. human,. needs
D. Pathophysiologic,. needs
ANS:,.B
The, . NANDA, . I, . taxonomy, . identifies, . human, . response, . patterns.,.Fu
nctional,.components,.of,.health,.patterns,.are,.limited,.to,.activity,,.fluid,.vol
ume,,.nutrition,,.self,.care,,.and,.sensory,.perception.,.Basic,.human,.needs,.c
omprise,.less,.than,.merely,.health,.patterns.,.Pathophysiologic,.needs,.are, .
not,.part,.of,.the,.scope,.of,.NANDA,.I.
, DIF:,.Cognitive,.Level:,.Knowledge,.RE
F:,.pp.,.37-38,.OBJ:,.5,.TOP:
Nursing,.Process,.Step:,.Diagnosis
MSC:,.NCLEX,. Client,. Needs,. Category:,. Physiological,. Integrity
• Which,.task,. is,. included,. in,.the,. assessment,.step,. of,.the,. nursing, . process?
A. Establishing, . patient, . goals/outcomes
B. Implementing,. the, . nursing,. care,. plan,. (NCP)
C. Measuring,. goal/outcome, . achievement
D. Collecting,.and,. communicating, . data
ANS:,.D
Data,.are,.collected,.and,.communicated,.in,.the,.assessment,.phase,.of,.the,.nur
sing,.process.,.Establishing,.goals,.is,.the,.function,.of,.planning.
Implementing,.the,.NCP,.is,.the,.function,.of,.implementation.,.Measuring,.out
come,.achievement,.is,.the,.function,.of,.evaluation.
DIF:,.Cognitive,.Level:,.Comprehensio
n,.REF:,.dm,.36,.OBJ:,.2,.|,.3,.TOP:,.Nursi
ng,.Process,.Step:,.Assessment
MSC:,.NCLEX,. Client,. Needs,. Category:,. Health,.Promotion,. and,. Maintenance
• Which,.statement,. regarding,. nursing,. diagnoses,. is, . accurate?
a. Nursing,.diagnoses,. remain,.the,.same,. for,. as,. long,.as,.the,.disease,. is, . present.
b. Nursing,. diagnoses,. are,. written,. to,. identify,.disease,.states.
c. Nursing,. diagnoses,. describe,. patient,. problems,. that,. nurses, . treat.
d. Nursing,. diagnoses,. identify,. causes,. related,. to,. illness.
ANS:,.C
Diagnostic,.statements,.identify,.problems,.a,.nurse,.is,.independently,.able,.t
o,.treat,.within,.the,.scope,.of,.professional,.practice.,.Nursing,.diagnoses,.var
y,.with,.the,.changing,.condition,.of,.the,.patient.,.The,.response,.patterns,.are,.
unique,.to,.the,.patient,.and,.are,.not,.disease,.specific.,.Nursing,.diagnoses,.de
scribe,.the,.patients,.human,.response,.pattern.
DIF:,. Cognitive,. Level:,. Comprehension
Advanced,.Pharmacology,.for,.Prescribers,.1st,.Edition,.Luu,.Kayingo,.Latest,
.Edition,,.2024
, Table,.of,.Contents
Chapter,. 1:,. An,.Introduction,. to,.Evidence-Based,.Clinical,. Practice,.Guidelines........................................ 3
Chapter,. 2:,.Pharmacokinetics ,. /Chapter3:,.Pharmacodynamics ............................................................... 13
Chapter4:,.Pharmacogenetics,. and,.Pharmacogenomics ........................................................................... 25
Chapter,. 5:,.Pharmacology,. Across,.the,.Life,.Span .................................................................................. 30
Chapter,. 6:,.Drug-Therapy,.Prescribing,. in,.Special,.Populations .............................................................. 36
Chapter,. 7:,.Drug,.Development ,. and,. Approval....................................................................................... 45
Chapter,.8-Chapter,.10:,.Foundations,.of,.Prescription,.Writing,.Chapter,.9:,.ResponsibleControlled-
Substance,.Prescribing,.Chapter,.10:,.Antibiotic,.Stewardship ................................................................... 51
Chapter,. 11:,. Applied,.Calculations,. for,. Prescribing ................................................................................ 58
Chapter,.12-:,.Promoting,.Adherence,.With,.Pharmacotherapy,.II:,.System-Specific,.and,.Patient-
Focused,.Prescribing,.Chapter,.13:,.Pharmacotherapy,.for,.Ear,,.Nose,,.Mouth,,.andThroat,.Conditions,./Chapt
er,.14:,.Pharmacotherapy,.for,.Eye,.Conditions.......................................................................................... 67
Chapter,. 15:,.Pharmacotherapy,.for,. Skin,.Conditions .............................................................................. 74
Chapter,. 16:,.Pharmacotherapy,.for,. Neurologic,. Conditions .................................................................... 81
Chapter,. 17:,.Pharmacotherapy,.for,. Cardiovascular,. Conditions ............................................................. 94
Chapter,. 18:,.Pharmacotherapy,. for,. Respiratory,.Conditions ................................................................. 106
Chapter,.19:,.Pharmacotherapy,.for,.Gastrointestinal,.Conditions,.and,.Conditions,.RequiringNutritional,.Sup
port ...................................................................................................................................................... 117
Chapter,. 20:,.Pharmacotherapy,.for,. Genitourinary,.Conditions.............................................................. 128
Chapter,.21:,.Pharmacotherapy,.for,. Renal,,. Acid–Base,,. Fluid, ,.and,.Electrolyte,.Disorders .................... 133
Chapter,. 22:,.Pharmacotherapy,.for,. Musculoskeletal,. and,. Rheumatologic,. Conditions ......................... 146
Chapter,. 23:,.Therapeutic,. Applications,. of,. Immunology,. and,. Vaccines ............................................... 158
Chapter,. 24:,.Pharmacotherapy,.for,. Endocrine,.Disorders ..................................................................... 163
Chapter,. 25:,.Pharmacotherapy,.for,.Hematologic,. Disorders ................................................................. 174
Chapter,. 26:,.Hematology/Oncology,.and,.Supportive,. Care,.for,. the,.Nononcologist .............................. 190
Chapter, . 27:,.Pharmacotherapy,. Related,. to,.Women’s,. Health,. Conditions ............................................ 196
Chapter,.28:,.Pharmacotherapy,. Related,.to,.Men’s,. Health,. Conditions ................................................. 211
Chapter,. 29:,.Pharmacotherapy,. Related,. to,.Transgender,. Care ............................................................. 217
Chapter,. 30:,. Antimicrobial,.Pharmacotherapy ...................................................................................... 224
Chapter,. 31:,. Antiretroviral,.Pharmacotherapy....................................................................................... 235
Chapter,.32:,.Psychopharmacology,.and,.Integrative,.Health:,.Combined,.Treatment,.ofPsychiatric,.and,.Neur
ocognitive,.Conditions .......................................................................................................................... 247
Chapter, . 33:,.Pharmacotherapy,. for,. Pain,.Management ......................................................................... 257
Chapter,. 34:,.Substance,. Use,.Disorder,. III:,.Health,.Promotion,.and,.Maintenance .................................. 267
Chapter,. 35:,.Over-the-Counter,. Medications ........................................................................................ 283
Chapter,. 36:,.Pharmacotherapy,.for,. Obesity .......................................................................................... 291
,Chapter,.1:,.An,. Introduction,. to,.Evidence-Based,. Clinical,.Practice,.Guidelines
MULTIPLE,.CHOICE
• What,. is,.the,.primary,.purpose,. of,.the,. nursing, . assessment?
A. Identifying,. underlying, . pathologic, . conditions
B. Assisting,. the,. physician,. in,. identifying,. medical,. conditions
C. Determining,. the,. patients,.mental,.status
D. Exploring,. patient,. responses,. to, . health,. problems
ANS:,.D
A,.nursing,.assessment,.is,.done,.to,.identify,.the,.patients,.response,.to,.health,.
problems.,.During,.the,.nursing,.assessment,.phase,,.a,.comprehensive,.inform
ation,.base,.is,.developed,.through,.a,.physical,.examination,,.nursing,.history,,
.medication,.history,,.and,.professional,.observation.,.Identifying,.underlying,
.pathologic,.conditions,.and,.assisting ,.the,.physician,.in,.identifying,.medical,.
conditions,.is,.not,.part,.of,.the,.nursing,.process.,.Determining,.the,.patients, .
mental,.status, . is, . one,.part, . of,.the, . nursing, . assessment,, . but, . it, . is, . not,.the,
.primary,.purpose.
DIF:,.Cognitive,.Level:,.Comprehension
,.REF:,.dm,.36 ,.OBJ:,.1,.|,.3,.TOP:,.Nursin
g,.Process,.Step:,.Assessment
MSC:,.NCLEX,. Client,. Needs,. Category:,. Health,.Promotion,. and,. Maintenance
• What,.is,.the,.basis,. of,.the,.NANDA,.I, . taxonomy?
A. Functional,. health,.patterns
B. Human,.response,. patterns
C. Basic,. human,. needs
D. Pathophysiologic,. needs
ANS:,.B
The, . NANDA, . I, . taxonomy, . identifies, . human, . response, . patterns.,.Fu
nctional,.components,.of,.health,.patterns,.are,.limited,.to,.activity,,.fluid,.vol
ume,,.nutrition,,.self,.care,,.and,.sensory,.perception.,.Basic,.human,.needs,.c
omprise,.less,.than,.merely,.health,.patterns.,.Pathophysiologic,.needs,.are, .
not,.part,.of,.the,.scope,.of,.NANDA,.I.
, DIF:,.Cognitive,.Level:,.Knowledge,.RE
F:,.pp.,.37-38,.OBJ:,.5,.TOP:
Nursing,.Process,.Step:,.Diagnosis
MSC:,.NCLEX,. Client,. Needs,. Category:,. Physiological,. Integrity
• Which,.task,. is,. included,. in,.the,. assessment,.step,. of,.the,. nursing, . process?
A. Establishing, . patient, . goals/outcomes
B. Implementing,. the, . nursing,. care,. plan,. (NCP)
C. Measuring,. goal/outcome, . achievement
D. Collecting,.and,. communicating, . data
ANS:,.D
Data,.are,.collected,.and,.communicated,.in,.the,.assessment,.phase,.of,.the,.nur
sing,.process.,.Establishing,.goals,.is,.the,.function,.of,.planning.
Implementing,.the,.NCP,.is,.the,.function,.of,.implementation.,.Measuring,.out
come,.achievement,.is,.the,.function,.of,.evaluation.
DIF:,.Cognitive,.Level:,.Comprehensio
n,.REF:,.dm,.36,.OBJ:,.2,.|,.3,.TOP:,.Nursi
ng,.Process,.Step:,.Assessment
MSC:,.NCLEX,. Client,. Needs,. Category:,. Health,.Promotion,. and,. Maintenance
• Which,.statement,. regarding,. nursing,. diagnoses,. is, . accurate?
a. Nursing,.diagnoses,. remain,.the,.same,. for,. as,. long,.as,.the,.disease,. is, . present.
b. Nursing,. diagnoses,. are,. written,. to,. identify,.disease,.states.
c. Nursing,. diagnoses,. describe,. patient,. problems,. that,. nurses, . treat.
d. Nursing,. diagnoses,. identify,. causes,. related,. to,. illness.
ANS:,.C
Diagnostic,.statements,.identify,.problems,.a,.nurse,.is,.independently,.able,.t
o,.treat,.within,.the,.scope,.of,.professional,.practice.,.Nursing,.diagnoses,.var
y,.with,.the,.changing,.condition,.of,.the,.patient.,.The,.response,.patterns,.are,.
unique,.to,.the,.patient,.and,.are,.not,.disease,.specific.,.Nursing,.diagnoses,.de
scribe,.the,.patients,.human,.response,.pattern.
DIF:,. Cognitive,. Level:,. Comprehension
